bd 1047 has been researched along with alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol in 2 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Trials (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Recent Studies (post-2010) (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 90 | 1 | 2 |
| Protein | Taxonomy | bd 1047 (IC50) | alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.83 | |
| Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | 6.43 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.83 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.8267 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.91 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.8267 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.5 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 1.5 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 1.5 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.8267 | |
| D(2) dopamine receptor | Mus musculus (house mouse) | 2.431 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 6.9225 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.06 | |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | 0.073 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beitz, AJ; Han, HJ; Kim, HW; Kim, KW; Kwon, YB; Lee, JH; Roh, DH; Yoon, SY | 1 |
| Hall, FS; Kitanaka, J; Kitanaka, N; Morita, Y; Nishiyama, N; Takemura, M; Tanaka, K; Tatsuta, T; Uhl, GR | 1 |
2 other study(ies) available for bd 1047 and alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
| Article | Year |
|---|---|
Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.
Topics: Animals; Ethylenediamines; Formaldehyde; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain Measurement; Phosphorylation; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pyrimidines; Receptor, Serotonin, 5-HT1A; Receptors, N-Methyl-D-Aspartate; Receptors, sigma | 2006 |
Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
Topics: Animals; Behavior, Animal; Butyrates; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Ethylenediamines; Histamine H1 Antagonists; Ketotifen; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Naphthalenes; Phenazocine; Piperazines; Pyrilamine; Pyrimidines; Receptors, sigma; Stereotyped Behavior; Tropanes | 2009 |